apyrase and Burns

apyrase has been researched along with Burns* in 2 studies

Other Studies

2 other study(ies) available for apyrase and Burns

ArticleYear
Burned to the bone.
    Science translational medicine, 2014, Sep-24, Volume: 6, Issue:255

    Heterotopic ossification--a complication of severe burns, head or blast injuries, and orthopaedic trauma--can result from altered adenosine metabolism in mesenchymal stem cells in response to elevated extracellular ATP (Peterson et al., this issue).

    Topics: Achilles Tendon; Adenosine Triphosphate; Animals; Apyrase; Burns; Female; Humans; Male; Mesenchymal Stem Cells; Ossification, Heterotopic; Osteogenesis

2014
Treatment of heterotopic ossification through remote ATP hydrolysis.
    Science translational medicine, 2014, Sep-24, Volume: 6, Issue:255

    Heterotopic ossification (HO) is the pathologic development of ectopic bone in soft tissues because of a local or systemic inflammatory insult, such as burn injury or trauma. In HO, mesenchymal stem cells (MSCs) are inappropriately activated to undergo osteogenic differentiation. Through the correlation of in vitro assays and in vivo studies (dorsal scald burn with Achilles tenotomy), we have shown that burn injury enhances the osteogenic potential of MSCs and causes ectopic endochondral heterotopic bone formation and functional contractures through bone morphogenetic protein-mediated canonical SMAD signaling. We further demonstrated a prevention strategy for HO through adenosine triphosphate (ATP) hydrolysis at the burn site using apyrase. Burn site apyrase treatment decreased ATP, increased adenosine 3',5'-monophosphate, and decreased phosphorylation of SMAD1/5/8 in MSCs in vitro. This ATP hydrolysis also decreased HO formation and mitigated functional impairment in vivo. Similarly, selective inhibition of SMAD1/5/8 phosphorylation with LDN-193189 decreased HO formation and increased range of motion at the injury site in our burn model in vivo. Our results suggest that burn injury-exacerbated HO formation can be treated through therapeutics that target burn site ATP hydrolysis and modulation of SMAD1/5/8 phosphorylation.

    Topics: Achilles Tendon; Adenosine Triphosphate; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Apyrase; Burns; Case-Control Studies; Cells, Cultured; Child; Child, Preschool; Disease Models, Animal; Female; Gene Expression Regulation; Gene Regulatory Networks; Humans; Hydrolysis; Infant; Infant, Newborn; Male; Mesenchymal Stem Cells; Mice, Inbred C57BL; Middle Aged; Ossification, Heterotopic; Osteogenesis; Phosphorylation; Signal Transduction; Smad Proteins, Receptor-Regulated; Tenotomy; Time Factors; Young Adult

2014